Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
ZYXI.US
id: 1026, Created by , Scout

Zynex (ZYXI) Delay in Issuing Q4’22 and Full Year 2022 Results Case

  • On March 6, 2023, Zynex announced delay in release of its Q4 and full year financial results and conference call initially scheduled for March 6, 2023.
  • On it, $ZYXI fell 21%, losing $89M+ of shareholder value.
  • Investors may have grounds to suspect Zynex of withholding its financial information, which led to their losses.
On March 6, 2023, Zynex announced that the Company was postponing release of its fourth quarter and full year financial results and conference call initially scheduled for March 6, 2023 to allow additional time to complete its year-end closing procedures.

On this news, $ZYXI fell 21% and lost over $89 million of its market capitalization, seriously damaging shareholders.

Considering all the information, investors might have grounds to suspect that Zynex was withholding its financial information, which led to their losses.

The case is already under investigation by at least one of the reputable law firms.
Alleged Offence
Misleading Statements
Failure to Disclose
Other
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
07 March 2023
Collecting participants…

Zynex Inc

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with e...

    Ticker
    ZYXI.US
    ISIN
    US98986M1036
    CIK
    846475
    Sector
    Healthcare
    Industry
    Medical Distribution
    Country
    USA
    Address
    9655 Maroon Circle, Englewood, CO, United States, 80112